These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 22722806

  • 1. Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.
    Foldenauer ME, McClellan SA, Barrett RP, Zhang Y, Hazlett LD.
    Cornea; 2012 Oct; 31(10):1176-88. PubMed ID: 22722806
    [Abstract] [Full Text] [Related]

  • 2. VIP promotes resistance in the Pseudomonas aeruginosa-infected cornea by modulating adhesion molecule expression.
    Berger EA, McClellan SA, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5776-82. PubMed ID: 20592225
    [Abstract] [Full Text] [Related]

  • 3. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA, Zhang Y, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HGF signaling impacts severity of Pseudomonas aeruginosa keratitis.
    Jiang X, McClellan SA, Barrett R, Foldenauer M, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2014 Apr 09; 55(4):2180-90. PubMed ID: 24618323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of the Fas pathway in Pseudomonas aeruginosa keratitis.
    Zhou Z, Wu M, Barrett RP, McClellan SA, Zhang Y, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2010 May 09; 51(5):2537-47. PubMed ID: 20019368
    [Abstract] [Full Text] [Related]

  • 8. VIP and growth factors in the infected cornea.
    Jiang X, McClellan SA, Barrett RP, Berger EA, Zhang Y, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2011 Aug 03; 52(9):6154-61. PubMed ID: 21666233
    [Abstract] [Full Text] [Related]

  • 9. Gene expression of pro-inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa.
    Xue ML, Thakur A, Willcox M.
    Clin Exp Ophthalmol; 2002 Jun 03; 30(3):196-9. PubMed ID: 12010214
    [Abstract] [Full Text] [Related]

  • 10. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD, McClellan SA, Barrett RP, Liu J, Zhang Y, Lighvani S.
    Invest Ophthalmol Vis Sci; 2007 Feb 03; 48(2):797-807. PubMed ID: 17251480
    [Abstract] [Full Text] [Related]

  • 11. Interleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.
    Li C, McClellan SA, Barrett R, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2014 Oct 08; 55(10):6886-900. PubMed ID: 25298414
    [Abstract] [Full Text] [Related]

  • 12. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2006 Nov 08; 47(11):4910-6. PubMed ID: 17065506
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of VIP in cornea.
    Jiang X, McClellan SA, Barrett RP, Zhang Y, Foldenauer ME, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2012 Nov 07; 53(12):7560-6. PubMed ID: 23074208
    [Abstract] [Full Text] [Related]

  • 15. Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis.
    Berger EA, Vistisen KS, Barrett RP, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2012 Nov 01; 53(12):7432-9. PubMed ID: 23036997
    [Abstract] [Full Text] [Related]

  • 16. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray.
    Huang X, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2003 Aug 01; 44(8):3409-16. PubMed ID: 12882789
    [Abstract] [Full Text] [Related]

  • 17. TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway.
    Sun M, Zhu M, Chen K, Nie X, Deng Q, Hazlett LD, Wu Y, Li M, Wu M, Huang X.
    Invest Ophthalmol Vis Sci; 2013 May 17; 54(5):3451-62. PubMed ID: 23611998
    [Abstract] [Full Text] [Related]

  • 18. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X, Barrett RP, McClellan SA, Hazlett LD.
    Invest Ophthalmol Vis Sci; 2005 Nov 17; 46(11):4209-16. PubMed ID: 16249500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.